Hemolysis: all 186 studies

Page 2 of 2. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.

• Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKAStatus unknownNCT04462614Not applicable
• Hereditary Spherocytosis and Vascular FunctionCompletedNCT04451785Not applicable
• The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic AnemiaActive, not recruitingNCT04398459Phase 2
• HEMolysis in a Percutaneous Axial Flow LVAD, Effects of Pentoxifylline in a Randomized Controlled TrialWithdrawnNCT04391231Phase 4
• Congenital Heart Surgery in Pediatric Patients With Beta-Thalassemia MajorCompletedNCT04367701
• ALXN1830 in Patients With Warm Autoimmune Hemolytic AnemiaWithdrawnNCT04256148Phase 2
• Meropenem and Piperacillin Plasma Concentrations During CRRTCompletedNCT04203784
• Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUSTerminatedNCT04132375Phase 2/3
• Intradialytic Exercise on the Fatigue, Sleep Disorder, Arterial Stiffness and Endothelial Function in Uremic PatientsCompletedNCT04098848Not applicable
• Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular InjuryCompletedNCT04084301Not applicable
• Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic AnemiaCompletedNCT04083014Phase 2
• Primaquine Enantiomers in G6PD Deficient Human VolunteersCompletedNCT04073953Phase 1
• A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITPWithdrawnNCT04039477Phase 2
• Data Registry of Auto Immune Hemolytic AnemiaStatus unknownNCT04024202
• The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia MajorCompletedNCT03948737Not applicable
• Ibrutinib in Steroid Refractory Autoimmune Hemolytic AnemiaStatus unknownNCT03827603Phase 2
• Erythropoietin in Hemolytic Uremic SyndromeCompletedNCT03776851Phase 4
• Effects of Nitric Oxide on the Endothelium During Hemolysis.WithdrawnNCT03748082Phase 2
• Outcame of Cases With Hemolytic Uremic Syndrome Attending Assiut University Child HospitalStatus unknownNCT03690024
• Home Hemodialysis Assisted by a Nurse for Arterio-venous Fistula CannulationStatus unknownNCT03633435Not applicable
• Fluid Distribution Timetable on Adherence to Fluid Restriction of Patients With End-Stage Renal Disease on HemodialysisCompletedNCT03582592Not applicable
• Usefulness of a Diagnostic Algorithm to Diagnose Thrombotic Microangiopathies in PregnancyStatus unknownNCT03580941
• Effects of Exercise on Physical Fitness Among Hemodialysis Patients With Chronic Kidney DiseaseCompletedNCT03579537Not applicable
• Eculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated aHUS: A Case SeriesStatus unknownNCT03574506
• Effect of in Vitro Haemolysis on Serum High Sensitivity Troponin T Measurements From Patients in Accident & EmergencyCompletedNCT03439605
• Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney DiseasesCompletedNCT03434145
• Validation of the GenePOC Strep A, C/G Assay for Detecting Group A, C and G β-hemolytic Streptococcus From Throat Swabs.CompletedNCT03422341Not applicable
• Controlled Human Infection for Vaccination Against Streptococcus PyogenesCompletedNCT03361163Phase 1
• Effect of Haemodialysis on the Efficacy of Antiplatelet AgentsStatus unknownNCT03330223
• A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic SyndromeWithdrawnNCT03303313Phase 2
• Shiga Toxin Producing Escherichia Coli (STEC) Volume ExpansionWithdrawnNCT03275792Phase 1
• Clinical Characteristics and Treatment Outcomes of Patients With Autoimmune Hemolytic AnemiaCompletedNCT03269292
• Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major ChildrenCompletedNCT03133169
• Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility DiseaseStatus unknownNCT03130517Early Phase 1
• Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational RunnersCompletedNCT02996786Not applicable
• Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department.CompletedNCT02976610Not applicable
• Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of HemolysisCompletedNCT02924792
• Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and AdultsCompletedNCT02904863Not applicable
• Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA)CompletedNCT02828670
• Investigating the Influence of Haemolysis on the Potassium Concentration After Capillary Blood SamplingCompletedNCT02711332
• Bendamustine and Rituximab Combination Therapy for Cold Agglutinin DiseaseCompletedNCT02689986Phase 2
• The Role of Microparticles as a BiomarkerWithdrawnNCT02626663
• A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)CompletedNCT02612558Phase 2
• The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic DisordersTerminatedNCT02472509Phase 4
• Complement Inhibition in aHUS Dialysis PatientsTerminatedNCT02464891Phase 2
• Isoagglutinins in the Development of IVIG-associated HemolysisCompletedNCT02259478
• Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood TransfusionWithdrawnNCT02217683Phase 2
• Immunoglobulin Dosage and Administration Form in CIDP and MMNCompletedNCT02111590
• Pyruvate Kinase Deficiency Natural History StudyCompletedNCT02053480
• Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory StudyWithdrawnNCT01888614
• Carbon Monoxide Monitor for the Measurement of End-Tidal Carbon Monoxide Levels in Children With or Without HemolysisCompletedNCT01848691Not applicable
• Hemolysis in Blood Samples in the ERCompletedNCT01815931
• A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT01770951
• The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT01757431Phase 2
• To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS PatientsCompletedNCT01755429
• R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell TransfusionsCompletedNCT01616329
• An Open Label Study of the Effects of Eculizumab in CD59 DeficiencyStatus unknownNCT01579838Phase 1/2
• Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.Status unknownNCT01579110Phase 2
• aHUS Observational Long Term Follow-UpTerminatedNCT01522170
• The Plasma Large-Volume Exchange RCTWithdrawnNCT01433003Phase 3
• Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)CompletedNCT01410916Phase 2/3
• Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4CompletedNCT01406288
• A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic AnemiaCompletedNCT01345708Phase 2
• Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood DisordersCompletedNCT01316796Phase 1
• The Effect of Antioxidant Vitamin Supplementation on Muscle Performance and Redox Status After Eccentric TrainingCompletedNCT01290458Not applicable
• Hemolysis in Patients With Hereditary Spherocytosis (HS)Status unknownNCT01201174Not applicable
• Rituximab in Auto-Immune Hemolytic AnemiaCompletedNCT01181154Phase 3
• Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic AnemiaCompletedNCT01134432Phase 3
• Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney DiseaseCompletedNCT00930423
• Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of HemolysisWithdrawnNCT00917007
• Probiotic Ingestion and Isoagglutinin TitersCompletedNCT00891787Phase 1
• Long Term Effects of Erythrocyte LysisCompletedNCT00842621
• Protective Effect of Propofol Against Hemolysis in Patients Submitted to GastroplastyStatus unknownNCT00792779Not applicable
• Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune CytopeniasCompletedNCT00749112Phase 2/3
• Evaluation of Toxicity From Stem Cell TransplantCompletedNCT00631787
• International Registry and Biorepository for TMA(Thrombotic Microangiopathy)TerminatedNCT00593229
• Rituximab in Patients With Relapsed or Refractory TTP-HUSStatus unknownNCT00531089Phase 2
• The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)CompletedNCT00358306
• Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary HypertensionCompletedNCT00352430Phase 1
• Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid PhenotypesTerminatedNCT00102245
• Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic DiseaseCompletedNCT00010387Phase 2
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesStatus unknownNCT00006055Not applicable
• Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic SyndromeTerminatedNCT00004465Phase 3
• Phase II Randomized Study of Tin Mesoporphyrin for Neonatal HyperbilirubinemiaCompletedNCT00004381Phase 2
• Combination Drug Therapy for Patients With Hepatitis CCompletedNCT00001729Phase 3
• Treatment of Autoimmune Thrombocytopenia (AITP)CompletedNCT00001630Phase 1

← Hemolysis overview